Pharmaceutical Supply – Bupivacaine Hydrochloride Injection

The contract entails the supply and delivery of 1,000 PG of sterile Bupivacaine Hydrochloride Injection, manufactured and packaged to comply with FDA and USP standards, ensuring pharmaceutical quality and safety for military medical use. The product must include both NSN and NDC labeling as required for federal procurement and inventory tracking, and shall be shipped FOB destination to Fort Bragg, North Carolina, placing the responsibility for transportation, risk, and delivery timing on the supplier until the goods reach the specified military location. This agreement is structured as a subcontract under the Department of Defense, managed by the Defense Logistics Agency, with the NAICS code 325412 indicating classification within pharmaceutical preparation manufacturing. The solicitation was posted on July 20, 2026, and the specific contract and delivery details are accessible via the DIBBS system. While no set-aside classification is indicated, the requirement is part of a broader defense healthcare supply chain, prioritizing consistent availability of essential anesthetic agents for field and hospital use.